A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure
- PMID: 11193411
- DOI: 10.1271/bbb.64.2420
A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure
Abstract
Staphylococcus warneri ISK-1, which we had previously reported as Pediococcus sp. ISK-1, produces a novel bacteriocin, nukacin ISK-1. Edman degradation of the chemically reduced nukacin ISK-1 produced a sequence of 27 amino acids, 7 of which were unidentified. Using single-specific-primer-PCR product as a probe, a 3.6-kb HindIII fragment containing the nukacin ISK-1 structural gene (nukA) was cloned and sequenced. The deduced amino acid sequence of nukacin ISK-1 had 57 amino acids, including a 30-amino acid leader region. The propeptide sequence showed significant similarity to those of lacticin-481 type lantibiotics. In the region upstream of nukA, a part of a long open reading frame (ORF), designated as nukM, encoding a putative modification enzyme was oriented in the opposite direction. In the region downstream of nukA, ORF1 was found in which the sequence of the putative translational product was similar to various response regulatory proteins.
Similar articles
-
Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.Biosci Biotechnol Biochem. 2004 Aug;68(8):1663-71. doi: 10.1271/bbb.68.1663. Biosci Biotechnol Biochem. 2004. PMID: 15322349
-
Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.J Mol Microbiol Biotechnol. 2007;13(4):235-42. doi: 10.1159/000104749. J Mol Microbiol Biotechnol. 2007. PMID: 17827974
-
Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.Vet Microbiol. 2010 Nov 20;146(1-2):124-31. doi: 10.1016/j.vetmic.2010.04.032. Epub 2010 May 11. Vet Microbiol. 2010. PMID: 20627619
-
Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.Peptides. 2009 Aug;30(8):1412-20. doi: 10.1016/j.peptides.2009.05.021. Epub 2009 May 27. Peptides. 2009. PMID: 19481127
-
The biology of lantibiotics from the lacticin 481 group is coming of age.FEMS Microbiol Rev. 2007 Mar;31(2):134-67. doi: 10.1111/j.1574-6976.2006.00045.x. Epub 2006 Nov 9. FEMS Microbiol Rev. 2007. PMID: 17096664 Review.
Cited by
-
Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus.Microbiol Spectr. 2023 Feb 14;11(1):e0303022. doi: 10.1128/spectrum.03030-22. Epub 2023 Jan 16. Microbiol Spectr. 2023. PMID: 36645288 Free PMC article.
-
Fighting biofilms with lantibiotics and other groups of bacteriocins.NPJ Biofilms Microbiomes. 2018 Apr 19;4:9. doi: 10.1038/s41522-018-0053-6. eCollection 2018. NPJ Biofilms Microbiomes. 2018. PMID: 29707229 Free PMC article. Review.
-
Bacteriocins of Non-aureus Staphylococci Isolated from Bovine Milk.Appl Environ Microbiol. 2017 Aug 17;83(17):e01015-17. doi: 10.1128/AEM.01015-17. Print 2017 Sep 1. Appl Environ Microbiol. 2017. PMID: 28667105 Free PMC article.
-
Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the Pathogenesis of Atopic Dermatitis.Microorganisms. 2019 Aug 29;7(9):301. doi: 10.3390/microorganisms7090301. Microorganisms. 2019. PMID: 31470558 Free PMC article. Review.
-
The draft genome of Staphylococcus warneri TRPF4, a bacteriocin producer with potent activity against the causative agent of Legionnaires' Disease.3 Biotech. 2020 May;10(5):232. doi: 10.1007/s13205-020-02231-3. Epub 2020 May 6. 3 Biotech. 2020. PMID: 32399382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources

